Literature DB >> 35028328

Novel adaptation of a running suture technique in a mouse model of corneal transplantation.

Hayate Nakagawa1, Tomas Blanco1, Francesca Kahale1, Rohan Bir Singh1, Thomas H Dohlman1, Reza Dana1.   

Abstract

Several murine models of corneal transplantation have been developed over the years to study the immunopathological processes that lead to the failure of grafted corneas. In all of them, the classic eight interrupted sutures technique is utilized for transplanting the donor cornea on the host bed. However, in clinical practice, a single continuous suture with a single knot is generally performed for corneal transplantation. Here, we describe the adaptation of the single continuous suture technique in a mouse model of corneal transplantation.
© 2013-2021 The Journal of Biological Methods, All rights reserved.

Entities:  

Keywords:  animal model; corneal transplantation; running suture technique

Year:  2021        PMID: 35028328      PMCID: PMC8748801          DOI: 10.14440/jbm.2021.373

Source DB:  PubMed          Journal:  J Biol Methods        ISSN: 2326-9901


INTRODUCTION

Over the past 115 years, keratoplasty has progressed to become the most widely performed solid tissue transplantation procedure [1]. In 2019, the Eye Bank Association of America reported 51336 corneal transplantations performed in the United States [2]. The development of experimental murine models of corneal transplantation beginning three decades ago has contributed greatly to our understanding of the pathological processes that lead to graft failure [3-8]. These models have been used to evaluate the host alloimmune response to the graft, to investigate the role of angiogenesis in the immunological response [9,10], and to assess the therapeutic effect of various immunomodulatory strategies [11-13]. In murine models of corneal transplantation, the most commonly used technique is the interrupted suturing method, in which a 2 mm donor corneal graft is secured to a 1.5 mm diameter recipient bed with eight interrupted (individual) 11-0 nylon sutures which are left un-buried [14]. Seven days post-transplant, the sutures are removed from the grafted cornea [15]. In clinical practice, surgeons performing corneal transplantation traditionally utilize a similar interrupted suturing technique, which allows for individual suture removal; however, the “running” suture technique, which consists of a single continuous suture with one knot, is also commonly performed. Potential benefits of the running suture technique include less irritation, suture loosening, and neovascularization [16], as well as even distribution of suture tension to reduce postoperative astigmatism [17,18]. Here, we report the adaptation of a continuous suturing method, commonly used in the clinical setting, to a murine model of corneal transplantation. Although a comparison between running and interrupted suture techniques has been described in the literature [19], here we provide a step-by-step description of the single continuous suture technique which will be of potential use for future investigators interested in using this model. Follow-up with slit-lamp photographs confirming the feasibility of this technique is shown. ✓ 6 to 8-week-old male/female* C57BL/6** mice (donor) ✓ 6 to 8-week-old male/female BALB/c mice (allogeneic recipient) *Age- and sex-matched mice have fewer variable outcomes. **Depending on the aim of the study, the technique can be applied to different strains, genders, ages, and animal models for donor and recipient animals ✓ Ocular viscoelastic device (OVD) (Bausch & Lomb, Rochester, NY, USA, Cat. # 59081L) ✓ Propacaine hydrochloride ophthalmic solution 0.5% (wt/vol), (Bausch & Lomb Incorporated, Tampa, FL, USA, NDC 24208-730-06) ✓ Phenylephrine ophthalmic solution 5% (ALTAIRE Pharmaceuticals, Inc., Aquebogue, NY, USA, NDC 59390-193-13) ✓ Tropicamide ophthalmic solution 1% (Bausch & Lomb Incorporated, Tampa, FL, USA, NDC 24208-590-64) ✓ Triple antibiotic eye ointment (Bacitracin Zinc, Neomycin, polymyxin B Sulfates), (Bausch & Lomb Incorporated, Tampa, FL, USA, NDC 24208-780-55) ✓ Ketamine (20 mg/kg) ✓ Xylazine (100–200 mg/kg) ✓ Buprenorphine (0.05–0.1 mg/kg) ✓ Sterile Phosphate Buffer Saline (PBS), (Life Technologies Corporation, Grand Island, NY, USA, Cat. # 10010-031) ✓ 11-0 nylon suture for corneal suturing (MANI, Inc., Tochigi, Japan, Cat. # 0550S) ✓ 8-0 nylon suture for eyelid tarsorrhaphy (MANI, Inc., Tochigi, Japan, Cat. # 2056) ✓ Jeweler’s forceps ✓ Scissors (Vannas and curved) ✓ Sterile 1.5 mm and 2 mm diameter trephines. (HealthLink, Jacksonville, FL, USA, Cat. # BP15, BP20) ✓ Sterile 25G and 30G needles ✓ Weck-cel sponges (Beaver Visitec International, Inc., Waltham, MA, USA, Cat. # 008680) ✓ Binocular surgical microscope ✓ Slit lamp

PROCEDURE

Mice were housed in the Schepens Eye Research Institute animal vivarium and treated according to the guidelines set forth by the Association for Research in Vision and Ophthalmology (ARVO). All animal experiments were reviewed and approved by the Institutional Animal Care and Use Committee. Obtaining the donor cornea Euthanize the donor C57BL/6 mouse via CO2 inhalation. Mark the central cornea with a 2 mm diameter trephine. Apply enough pressure to penetrate the deep stroma without perforating the cornea. With a 30 G needle, enter the anterior chamber: proper tunneling leads to leakage of aqueous humor and partial collapse of the anterior chamber. Inject OVD to restore the anterior chamber. Carefully dry the corneal surface with a Weck-cel sponge. Along the marked, trephined edge, excise the central cornea using Vannas scissors. Anesthesia Induce general anesthesia by intraperitoneal injection of ketamine (120 mg/kg) and xylazine (20 mg/kg) to the recipient BALB/c mouse. Apply one drop of 0.5% procainamide to the corneal surface as topical anesthesia. Preparing the graft bed Once the animal is fully anesthetized, achieve mydriasis using one drop of 2.5% phenylephrine hydrochloride and 1% tropicamide. Place the mouse in a recumbent lateral position, placing the head so the eye can be visualized under the surgical microscope. Wash the ocular surface with PBS and dry it using Weck-cel sponges. Mark the central cornea with a 1.5 mm diameter trephine. Apply enough pressure to penetrate the deep stroma without perforating the cornea. () Using a 30 G needle, enter the anterior chamber. Inject OVD to restore the anterior chamber. Carefully dry the surface with Weck-cel sponges. Along the marked, trephined edge, completely excise the central cornea using Vannas scissors and discard. Suturing the graft () Anchor the 2 mm donor cornea on the 1.5 mm recipient bed using a single interrupted 11-0 nylon suture at 12 o’clock, penetrating the donor graft first, and biting through 90% of the recipient corneal depth. Place three additional interrupted cardinal sutures at 3, 6, and 9 o’clock ( and ). During and after suture placement, inject OVD to maintain anterior chamber depth. Start the continuous suture using an 11-0 nylon between 12 and 1 o’clock, running clockwise, placing two evenly-spaced suture bites within each quadrant ( and ). Adjust suture tension along each suture segment. Wash the anterior chamber with PBS to remove OVD, maintaining the anterior chamber and achieving a physiologic intraocular pressure (). Adjust suture tension along each suture segment and permanently secure the suture knot once the desired tension is achieved ( and ). Remove the four cardinal interrupted sutures (). Final evaluation Observe the eye to make sure the pupil is round and the anterior chamber depth is normal ( and ). Apply antibiotic ointment to the operated eye. Perform tarsorrhaphy with an 8-0 nylon suture to close the eyelids Administer buprenorphine (0.05–0.1 mg/kg) by subcutaneous injection immediately after surgery to minimize post-operative pain. Suture removal At 24 hours post-transplantation, anesthetize mice as described above and remove tarsorrhaphy. At seven days post-transplantation, anesthetize mice as described above and cut the suture at one location in each quadrant and remove the suture (). Clinical assessment Examine eyes by slit-lamp microscopy weekly for eight weeks to assess corneal opacity and neovascularization using a standard scoring system [14].

RESULTS

The continuous suture technique was successfully developed in a mouse model of corneal transplantation, and no complications were observed through 8-weeks of follow-up (). All sutures remained in place and no suture breakage or changes in tension were observed. In contrast to corneal transplants with interrupted sutures, where neovascularization is sometimes observed due to un-buried suture knots, no neovascularization was observed in corneas with the continuous technique. During suture removal, we did not observe any complications such as aqueous humor leakage, anterior chamber decompensation, or graft dehiscence. Regarding the operative time for transplantation and suture removal, we found that the running suture technique requires more time for suturing the graft and less time for suture removal compared to the interrupted suture technique, but there was no difference in overall surgical time (). Incidentally, we observed fewer anterior synechiae in the continuous suture group (4/26 mice, 15%) as compared to the interrupted suture group (8/24 mice, 33%) (see for representative images). Anterior synechiae formation is a common complication in corneal transplantation which may increase the rate of graft rejection and future studies may be warranted to investigate the possible contribution of anterior synechiae to graft rejection and failure [20]. In conclusion, the continuous running suturing technique is feasible in a mouse model of corneal transplantation and represents an adaptation of a very well-established clinical technique to an animal model. The current report provides detailed step-by-step instructions for investigators to put this model into practice, and in future studies it will be important to compare the running and interrupted suture techniques in terms of clinical characteristics (neovascularization and graft opacity) and graft survival.

POTENTIAL COMPLICATIONS

Potential issues that may be encountered with corneal transplantation using the continuous suture technique are outlined below. A cataract is a major complication that results from physical contact with the lens capsule while preparing the recipient bed. Hemorrhage in the anterior chamber and subsequent hyphema formation may occur due to surgery-related trauma, typically due to accidental injury to the iris during the procedure. Anterior chamber washout with PBS may be performed to clear the anterior chamber. It is essential to keep the surgical field clear as a foreign body can become trapped within the suture and potentially result in suture breakage. Anterior synechiae between the iris and cornea may form and may be identified by slit lamp exam and/or anterior segment OCT. NOTES: These are typical complications observed with the classical interrupted technique, and although we cannot rule out other specific complications related to this new technique, it likely that encountered complications are related more to the surgical learning curve rather than the technique itself. Movie S1. The video included how to place the interrupted suture, how to start the continuous suture, how to adjust suture tension at the end.

Supplementary information

Supplementary information of this article can be found online at https://jbm.wistia.com/medias/xkkdlg2v01.
Table 1.

Surgical time using the running and interrupted suture techniques*.

Transplantation (min)Suture removal (min)Total time (min)
Running23.2 ± 2.84.7 ± 1.427.9 ± 3.0
Interrupted18.3 ± 2.69 ± 1.928 ± 2.7
P value0.0010.0010.920

*Min, minutes; data given as mean ± SD.

  20 in total

Review 1.  The immune privilege of corneal allografts.

Authors:  J Y Niederkorn
Journal:  Transplantation       Date:  1999-06-27       Impact factor: 4.939

2.  A method for performing full-thickness, orthotopic, penetrating keratoplasty in the mouse.

Authors:  S C She; L P Steahly; E J Moticka
Journal:  Ophthalmic Surg       Date:  1990-11

3.  Kinetics of Angiogenic Responses in Corneal Transplantation.

Authors:  Takenori Inomata; Alireza Mashaghi; Antonio Di Zazzo; Sang-Mok Lee; Homer Chiang; Reza Dana
Journal:  Cornea       Date:  2017-04       Impact factor: 2.651

4.  Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases.

Authors:  Maryam Tahvildari; Reza Dana
Journal:  J Immunol       Date:  2019-12-01       Impact factor: 5.422

5.  Increase in orthotopic murine corneal transplantation rejection rate with anterior synechiae.

Authors:  S Yamagami; T Tsuru
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-09       Impact factor: 4.799

6.  Penetrating corneal transplantation in the inbred rat: a new model.

Authors:  K A Williams; D J Coster
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-01       Impact factor: 4.799

7.  Orthotopic corneal transplantation in mice--evidence that the immunogenetic rules of rejection do not apply.

Authors:  Y Sonoda; J W Streilein
Journal:  Transplantation       Date:  1992-10       Impact factor: 4.939

8.  Ocular surgical models for immune and angiogenic responses.

Authors:  Takenori Inomata; Alireza Mashaghi; Antonio Di Zazzo; Reza Dana
Journal:  J Biol Methods       Date:  2015-09-21

9.  Treatment of donor corneal tissue with immunomodulatory cytokines: a novel strategy to promote graft survival in high-risk corneal transplantation.

Authors:  Maryam Tahvildari; Parisa Emami-Naeini; Masahiro Omoto; Alireza Mashaghi; Sunil K Chauhan; Reza Dana
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

Review 10.  Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.

Authors:  Tulio B Abud; Antonio Di Zazzo; Ahmad Kheirkhah; Reza Dana
Journal:  J Ophthalmic Vis Res       Date:  2017 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.